Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Marker Therapeutics Inc | MRKR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.06 | 1.01% | 6.00 | 6.04 | 5.86 | 5.87 | 5.94 | 12:15:42 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 5.98 | 6.00 | 0.02 | 0.33% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 274 | 40,503 | $ 5.94 | $ 240,489 | 322,208 | 3.97 - 10.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:16:10 | 37 | $ 5.98 | USD |
Marker Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 274.02M | 45.67M | $ -147.96M | -7.75 | - | 30.46M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Marker Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRKR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.87 | 6.22 | 5.6112 | 6.0057 | 243k | 0.13 | 2.21% |
| 1 Month | 5.13 | 6.54 | 4.64 | 5.5766 | 249k | 0.87 | 16.96% |
| 3 Months | 8.09 | 9.17 | 3.97 | 6.3426 | 561k | -2.09 | -25.83% |
| 6 Months | 5.95 | 9.17 | 3.97 | 6.3131 | 508k | 0.05 | 0.84% |
| 1 Year | 10.01 | 10.25 | 3.97 | 6.3143 | 388k | -4.01 | -40.06% |
| 3 Years | 10.01 | 10.25 | 3.97 | 6.3143 | 388k | -4.01 | -40.06% |
| 5 Years | 10.01 | 10.25 | 3.97 | 6.3143 | 388k | -4.01 | -40.06% |
Marker Therapeutics Description
| Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from our MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart. |
